Activation of the enzymes of phase I (CYP2B1/2) and phase II (SULT1A and COMT) metabolism by 2,2',4,4'-tetrabromodiphenyl ether (BDE47) in the pig ovary

Reproductive Toxicology

Volumn 34, Issue 3, 2012, Pages 436-442

  Karpeta, A ^a   Warzecha, K ^a   Jerzak, J ^a   Ptak, A ^a   Gregoraszczuk, E L ^a  

^a JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

BDE 47; COMT; CYP1A1; CYP2B1 2; Ovary; SULT1A

Indexed keywords

2,2',4,4' TETRABROMODIPHENYL ETHER; CATECHOL METHYLTRANSFERASE; CYTOCHROME P450 2B1; CYTOCHROME P450 2B2; POLYBROMINATED DIPHENYL ETHER; SULFOTRANSFERASE; SULFOTRANSFERASE 1A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL CULTURE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; EXPOSURE; FEMALE; NONHUMAN; OVARY; PROTEIN EXPRESSION; PROTEIN STABILITY; SWINE; XENOBIOTIC METABOLISM;

ANIMALS; ARYL HYDROCARBON HYDROXYLASES; ARYLSULFOTRANSFERASE; CATECHOL O-METHYLTRANSFERASE; CELLS, CULTURED; CYTOCHROME P-450 CYP2B1; FEMALE; OVARY; POLYBROMINATED BIPHENYLS; STEROID HYDROXYLASES; SWINE;

SUIDAE; SUS;

EID: 84865570386     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2012.06.009     Document Type: Article

References (42)

1. BSEF. Bromine Science and Enviromental Forum Available at: 2007 [accessed on 03.04.08]. http://www.bsef.com/.
2. Akutsu K., Hori S. Polybrominated diphenyl ether flame retardants in foodstuffs and human milk. Shokuhin Eiseigaku Zasshi 2004, 45:175-183.
3. Sjödin A., Patterson D.G., Bergman A. A review on human exposure to brominated flame retardants-particularly polybrominated diphenyl ethers. Environment International 2003, 29:829-839.
4. Marsh G., Athanasiadou M., Bergman A., Asplund L. Identification of hydroxylated and methoxylated polybrominated diphenyl ethers in Baltic Sea salmon (Salmo salar) blood. Environmental Science & Technology 2004, 38:10-18.
5. Marsh G., Athanasiadou M., Athanassiadis I., Sandholm A. Identification of hydroxylated metabolites in 2,2',4,4'-tetrabromodiphenyl ether exposed rats. Chemosphere 2006, 63:690-697.
6. Malmberg T., Athanasiadou M., Marsh G., Brandt I., Bergman A. Identification of hydroxylated polybrominated diphenyl ether metabolites in blood plasma from polybrominated diphenyl ether exposed rats. Environmental Science & Technology 2005, 39:5342-5348.
7. Bergman A., Athanasiadou M., Fäldt E., Jakobsson K. Hydroxylated PBDE metabolites in human blood. Organohalogen Compounds 2006, 68:635-638.
8. Malmvarn A., Marsh G., Kautsky L., Athanasiadou M., Bergman A., Asplund L. Hydroxylated and methoxylated brominated diphenyl ethers in the red algae Ceramium tenuicorne and blue mussels from the Baltic Sea. Environmental Science & Technology 2005, 39:2990-2997.
9. Hakkola J., Pasanen M., Hukkanen J., Pelkonen O., Mäenpää J., Edwards R.J., et al. Expression of xenobiotic-metabolizing cytochrome P450 forms in human full-term placenta. Biochemical Pharmacology 1996, 2351:403-411.
10. Nishimura M., Yaguti H., Yoshitsugu H., Naito S., Satoh T. Tissue distribution of mRNA expression of human cytochrome P450 isoforms assessed by high-sensitivity real-time reverse transcription PCR. Yakugaku Zasshi 2003, 123:369-375.
11. Mattison D.R., West D.M., Menard R.H. Differences in benzo(a)pyrene metabolic profile in rat and mouse ovary. Biochemical Pharmacology 1979, 28:2101-2104.
12. Cannady E.A., Dyer C.A., Christian P.J., Sipes I.G., Hoyer P.B. Expression and activity of cytochromes P450 2E1, 2A, and 2B in the mouse ovary: the effect of 4-vinylcyclohexene and its diepoxide metabolite. Toxicological Sciences 2003, 73:423-430.
13. Myers M.J., Farrell D.E., Howard K.D., Kawalek J.C. Identificationof multiple constitutive and inducible hepatic cytochrome P450 enzymes in market weight swine. Drug Metabolism and Disposition 2001, 29:908-915.
14. Leighton J.K., Canning S., Guthrie H.D., Hammond J.M. Expression of cytochrome P450 1A1, an estrogen hydroxylase, in ovarian granulosa cells is developmentally regulated. Journal of Steroid Biochemistry and Molecular Biology 1995, 52:351-356.
15. Ptak A., Ludewig G., Kapiszewska M., Magnowska Z., Lehmler H.J., Robertson L.W., et al. Induction of cytochromes P450, caspase-3 and DNA damage by PCB3 and its hydroxylated metabolites in porcine ovary. Toxicology Letters 2006, 166:200-211.
16. Ptak A., Ludewig G., Gregoraszczuk E.Ł. A low halogenated biphenyl (PCB3) increases CYP1A1 expression and activity via the estrogen receptor beta in the porcine ovary. Journal of Physiology and Pharmacology 2008, 59:577-588.
17. Kretschmer X.C., Baldwin W.S. CAR and PXR: xenosensors of endocrine disrupters. Chemico-Biological Interactions 2005, 155:111-128.
18. Salih S., Xu X., Veenstra T.D., Duleba A.J., Fouad H., Nagamani M., et al. Lower levels of urinary 2-hydroxyestrogens in polycystic ovary syndrome. Journal of Clinical Endocrinology & Metabolism 2007, 92:3285-3291.
19. Lin Z., Lou Y., Squires J.E. Molecular cloning and functional analysis of porcine SULT1A1 gene and its variant: a single mutation SULT1A1 causes a significant decrease in sulfation activity. Mammalian Genome 2004, 15:218-226.
20. Canton R.F., Scholten D.E., Marsh G., de Jong P.C., van den Berg M. Inhibition of human placental aromatase activity by hydroxylated polybrominated diphenyl ethers (OH-PBDEs). Toxicology and Applied Pharmacology 2008, 227:68-75.
21. Gregoraszczuk E.L., Bylica A., Gertler A. Response of porcine theca and granulosa cells to GH during short-term in vitro culture. Animal Reproduction Science 2000, 58:113-125.
22. Stoklosowa S., Bahr J., Gregoraszczuk E. Some morphological and functional characteristics of cells of the porcine theca interna in tissue culture. Biology of Reproduction 1978, 19:712-719.
23. Mulder G.J., Scholtens E Phenol sulphotransferase and uridine diphosphate glucuronyltransferase from rat liver in vivo and vitro. 2,6-Dichloro-4-nitrophenol as selective inhibitor of sulphation. Biochemical Journal 1977, 165:553-559.
24. Herblin W.F. A simple colorimetric assay for catechol-O-methyl transferase. Analytical Biochemistry 1973, 51:19-22.
25. Staskal D.F., Diliberto J.J., DeVito M.J., Birnbaum L.S. Toxicokinetics of BDE 47 in female mice: effect of dose, route of exposure, and time. Toxicological Sciences 2005, 83:215-223.
26. Sanders J.M., Burka L.T., Smith C.S., Black W., James R., Cunningham M.L. Differential expression of CYP1A, 2B, and 3A genes in the F344 rat following exposure to a polybrominated diphenyl ether mixture or individual components. Toxicological Sciences 2005, 88:127-133.
27. Pacyniak E.K., Cheng X., Cunningham M.K., Crofton K., Klaassen C.D., Guo G.L. The flame retardants, polybrominated diphenyl ethers, are pregnane X receptor activators. Toxicological Sciences 2007, 97:94-102.
28. Richardson V.M., Staskal D.F., Diliberto J.J., DeVito M.J., Birnbaum L.S. Possible mechanisms of thyroid hormone disruption in mice by BDE 47, a major polybrominated diphenyl ether congener. Toxicology and Applied Pharmacology 2008, 226:244-250.
29. Chen G., Bunce N.J. Polybrominated diphenyl ethers as Ah receptor agonists and antagonists. Toxicological Sciences 2003, 76:310-320.
30. Peters A.K., Van Londen K., Bergman A., Bohonowych J., Denison M.S., Van den Berg M., et al. Effects of polybrominateddiphenyl ethers on basal and TCDD-induced ethoxyresorufinactivity and cytochrome P450-1A1 expression in MCF-7, HepG2, and H4IIE cells. Toxicological Sciences 2004, 82:488-496.
31. Peters A.K., Nijmeijer S., Gradin K., Backlund M., Bergman A., Poellinger L., et al. Interactions of polybrominated diphenyl ethers with the aryl hydrocarbon receptor pathway. Toxicological Sciences 2006, 92:133-142.
32. Gregoraszczuk E.L., Ptak A., Skaare J.U., Mularz K., Chmielowiec A., Wojtowicz A., et al. Mechanisms of action of two different natural mixtures of persistent organic pollutants (POPs) in ovarian follicles. Xenobiotica 2009, 39:80-89.
33. Van den Berg M., Birnbaum L.S., Denison M., De Vito M., Farland W., Feeley M., et al. The 2005 World Health Organization reevaluation of human and mammalian toxic equivalency factors for dioxins and dioxin-like compounds. Toxicological Sciences 2006, 93:223-241.
34. Meerts I.A., Van Zanden J.J., Luijks E.A., Van Leeuwen-Bo I., Marsh G., Jakobsson E., et al. Potent competitive interactions of some brominated flame retardants and related compounds with human transthyretin in vitro. Toxicological Sciences 2000, 56:95-104.
35. Sanderson J.T., Seinen W., Giesy J.P., Van den Berg M. 2-Chloro-striazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity. Toxicological Sciences 2000, 54:121-127.
36. Nagata K., Yamazoe Y. Pharmacogenetics of sulfotransferase. Annual Review of Pharmacology and Toxicology 2000, 40:159-176.
37. Blanchard R.L., Freimuth R.R., Buck J., Weinshilboum R.M., Coughtrie M.W.H. A proposed nomenclature system for the cytosolic sulfotransferase (SULT) superfamily. Pharmacogenetics 2004, 14:199-211.
38. Wang L., Raghavan N., He K., Luettgen J.M., Humphreys W.G., Knabb R.M., et al. Sulfation of o-demethyl apixaban: enzyme identification and species comparison. Drug Metabolism and Disposition 2009, 37:802-808.
39. Kester M.H., Bulduk S., van Toor H., Tibboel D., Meinl W., Glatt H., et al. Potent inhibition of estrogen sulfotransferase by hydroxylated metabolites of polyhalogenated aromatic hydrocarbons reveals alternative mechanism for estrogenic activity of endocrine disrupters. Journal of Clinical Endocrinology & Metabolism 2002, 87:1142-1150.
40. Lachman H.M., Papolos D.F., Saito T., Yu Y.M., Szumlanski C.L., Weinshilboum R.M. Human catechol-O-methyltransferase pharmacogenetics: description of a functional polymorphism and its potential application to neuropsychiatric disorders. Pharmacogenetics 1996, 6:243-250.
41. Ho P.W., Garner C.E., Ho J.W., Leung K.C., Chu A.C., Kwok K.H., et al. Estrogenic phenol and catechol metabolites of PCBs modulate catechol-O-methyltransferase expression via the estrogen receptor: potential contribution to cancer risk. Current Drug Metabolism 2008, 9:304-309.
42. Salih S., Jamaluddin M., Salama S., Fadl A.A., Nagamani M., Al-Hendy A. Regulation of catechol O-methyltransferase expression in granulosa cells: a potential role for follicular arrest in polycystic ovary syndrome. Fertility and Sterility 2008, 89:1414-1421.